Antibacterial efficacy of KERRACEL™ Ag and Aquacel® Ag Extra™ against planktonic species over 7 days in vitro. CHC R539. 2017. Crawford Healthcare Ltd.

In vitro fluid handling properties of KERRACEL™ Ag and Aquacel® Ag Extra™. CHC R545. 2017. Crawford Healthcare Ltd.Evaluation of KERRACEL™ Ag and Aquacel® Ag Extra™ sequester bacteria. CHC R543. 2017. Crawford Healthcare Ltd. Zone of inhibition evaluation of KERRACEL™ Ag and Aquacel® Ag Extra™ to uniformly kill planktonic bacteria. CHC R544. 2017. Crawford Healthcare Ltd. This dressing is the only gelling dressing with Ag OXYSALTS™ Technology (Ag 3+), providing up to 6 times more power than traditional silvers (Ag 1+) * 1: Evaluation of antimicrobial activity of KERRACEL™ Ag and Aquacel® Ag Extra™ against in vitro biofilms. CHC R541. 2017. Crawford Healthcare Ltd. Jones N, Ivins N, Ebdon V, Hagelstein S, Harding K. A case series evaluating the use of a gelling fibre dressing for moderate to highly exuding wounds. Wounds UK 13: 3: 72-78.

An assessment of silver ribbon dressings using a porcine cavity model. CHC R530. 2017. Crawford Healthcare Ltd. Rate of antibacterial efficacy of KERRACEL™ Ag and Aquacel® Ag Extra™ against S. aureus and P. aeruginosa in vitro. CHC R540. 2017. Crawford Healthcare Ltd. Erbogasto D. Physical testing of KERRACEL™ Dressing and market competitors. R&D Trial Report CHC R1004. Knutsford, UK. Crawford Healthcare. 2020.Spina C. Silver I, II, III: Chemical characteristics, properties, and anti-microbial activity. Crawford Healthcare Ltd. A proven substrate, this dressing is a carboxymethyl cellulose (CMC) gelling fiber dressing designed to help create the optimal healing environment*: